ArticleAntimicrobial stewardship & healthcare epidemiology : ASHE2025
A case-control study of end-of-life antimicrobial use in Non-hospitalized hospice patients in the United States.
Article in Antimicrobial stewardship & healthcare epidemiology : ASHE, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Antimicrobials are frequently prescribed to hospice patients despite limited data on their utility. Methods/study design: We analyzed data on 1,111 hospice deaths from 2019. From these data, patients were divided into two groups: those who received antimicrobials at EOL (n = 212) and equally randomly computer-generated control group who did not. Fisher's exact test and Wilcoxon rank sum test were used for analysis. PPS was recorded and used to determine functional status; higher PPS equates to higher functional status. Multivariable logistic regression correlated patient characteristics with EOL antimicrobial status. Results: Higher PPS scores were significantly associated with increased likelihood of antimicrobial use (Odds Ratio [OR] 1.40, 95% Confidence Interval [CI] 1.16-1.70). Male patients (OR 0.60, 95% CI 0.40-0.90) and patients with cancer (OR 0.61, 95% CI 0.39-0.96) were associated with lower odds of receiving antimicrobials. No significant association was found with age, race/ethnicity, residence, illness, or code status. Conclusion: The study identifies an association between PPS and antimicrobial prescribing near EOL. Tailoring antimicrobial use based on individual patient characteristics and goals may better align with hospice care objectives and aid in stewardship endeavors. Further research is needed to explore PPS as a potential tool to guide prescribing.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.